The abstract is read at the publisher; the summary is JClub's.
High-frequency dupilumab and swallowed topical corticosteroids are likely among the most effective EoE treatments for symptoms, with MDs of -11.08 and -6.86, respectively.
- Why it matters: Comparative efficacy and safety across pharmacologic, dietary, and mechanical options for children and adults with EoE remain uncertain, limiting evidence-based treatment selection.
- What they did: A systematic review and random-effects network meta-analysis of 48 RCTs (3,963 participants) compared interventions using MEDLINE, EMBASE, and CENTRAL searches through March 17, 2026, with risk-of-bias assessment and GRADE certainty.
- The result: For quality-of-life, high-frequency dupilumab (MD 6.57) and STCs (MD 7.20) were among the most effective; multiple interventions reduced peak eosinophil counts, while FED benefits were modest and low-certainty.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.